3
Announcements
Trials
Browse
Landscape
Status
Recruiting
4
Completed
2
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
244
Nivolumab
140
Cisplatin
135
Cyclophosphamide
134
Paclitaxel
113
Carboplatin
108
Gemcitabine
98
Radiotherapy
83
Dexamethasone
83
Docetaxel
77
atezolizumab
68
Ipilimumab
68
Doxorubicin
62
Fluorouracil
60
Blood Specimen Collection
58
Bevacizumab
58
fludarabine
54
Rituximab
54
Etoposide
53
Oxaliplatin
52
Surveys and Questionnaires
49
Lenalidomide
49
Prednisone
47
Standard of Care
45
Magnetic Resonance Spectroscopy
45
Cetuximab
44
Capecitabine
44
lenvatinib
43
Radiosurgery
43
durvalumab
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Tumor Burden
×
1 year
×
Clear all
NCT05384184
2025-11-20
BORG
Assistance Publique Hopitaux De Marseille
Completed
48 enrolled
NCT03831230
2025-08-08
OVAREX
Centre Francois Baclesse
Completed
250 enrolled